
Colgate Palmolive (India) Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 28 Jan 2026 • 4:55 pm
Posted by:

Colgate Palmolive (India) Q3 results FY26 are scheduled to be announced on 29th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Colgate Palmolive (India) Q3 Results 2026 Preview
- Colgate Palmolive (India)'s revenue is expected to be in the range of ₹1,461.84 crore, a 9.71% YoY decrease.
- Profit After Tax, or PAT, is projected to fall by 18.29% YoY.
- Colgate Palmolive (India)'s EBITDA is expected to fall to ₹413.23 crore.
- Net profit is ₹322.78 crore, a fall 18.29% YoY
Colgate Palmolive (India) Share Performance
- Over the past six months, Colgate Palmolive (India )'s share price has fallen by 2.39% to ₹2,153.10.
- Moreover, over the past year, the stock has decreased by 19.64%.
- Despite this weak short-term performance, Colgate Palmolive (India )'s stock has delivered a financially sound 34.29% return over the past 5 years.
- As of 28th January 2026, the stock traded at ₹2,153.10 per share.
Key Factors to Watch for Colgate Palmolive (India) Q3 Results FY26
- Revenue & volume growth: Trend in net sales amid soft demand and prior GST‑linked disruptions in oral care channels.
- Profitability & margins: PAT and EBITDA margin performance relative to last year’s level and sequential improvement.
- Urban vs rural demand: Recovery in urban consumption and strength in rural markets influencing overall demand.
- Premiumisation & product mix: Traction in premium toothpaste ranges and new innovations driving higher‑value sales.
- Marketing & brand investments: Advertising and promotional spend aimed at supporting volume amid competition.
Final Thoughts
Colgate Palmolive (India) will announce its Q3 FY26 results on 29th January 2026. Analysts expect 9.71% YoY revenue growth, a 18.29% fall in PAT, and a 9.30% fall in EBITDA. Colgate-Palmolive (India) focuses recovery in organic demand and revenue growth after GST disruption, premiumisation and new product traction, while margins and urban sales trends guide profitability outlook.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Taurian MPS IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Colgate Palmolive (India)elerator IPO GMP & Review: Apply or Avoid?
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Nifty Bank Today: Index Ends 0.02% Lower at 57,514.20
Nifty Metal Today: Index Ends 0.07% Lower on 25 August
Nifty Mid Select Today: Index Rises 0.69% to 15,000.90
Nifty Pharma Today: Index Gains 0.85% to Close at 26,564
Nifty FMCG Today: Performance, Gainers, Losers & Analysis
Popular this week
Nifty Auto Today: Performance, Gainers, Losers & Analysis

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





